Investing.com - PetMed Express (NASDAQ: PETS) reported second quarter EPS of $0.110, $0.15 better than the analyst estimate of $-0.040. Revenue for the quarter came in at $59.6M versus the consensus estimate of $66M.
PetMed Express's stock price closed at $4.22. It is up 36.570% in the last 3 months and down -40.980% in the last 12 months.
PetMed Express saw positive EPS revisions and negative EPS revisions in the last 90 days. See PetMed Express's stock price’s past reactions to earnings here.
According to InvestingPro, PetMed Express's Financial Health score is "fair performance".
Check out PetMed Express's recent earnings performance, and PetMed Express's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar